Hjem › Munnhulekreft › Maryland › Baltimore
Kliniske studier for Munnhulekreft i Baltimore, MD
5 studier for Munnhulekreft søker deltakere på steder i og rundt Baltimore (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RekruttererFase 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
RekruttererFase 1
- University of Maryland/Greenebaum Cancer Center, Baltimore
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RekruttererFase 2
- Greater Baltimore Medical Center, Baltimore
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RekruttererFase 2
- Greater Baltimore Medical Center, Baltimore
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
RekruttererFase 2
- Johns Hopkins Hospital East Baltimore, Baltimore
Munnhulekreft-studier i andre byer
- Atlanta, GA9 studier
- St. Louis, MO8 studier
- New York City, NY8 studier
- Chicago, IL8 studier
- Durham, NC7 studier
- Houston, TX7 studier
- Ann Arbor, MI7 studier
- Portland, OR7 studier
- Pittsburgh, PA7 studier
- Milwaukee, WI7 studier
- Kansas City, MO7 studier
- Richmond, VA7 studier
Andre studier i Baltimore
- Ikke-småcellet lungekreft60 studier
- Brystkreft47 studier
- Prostatakreft43 studier
- Lungekreft40 studier
- Kreft (alle typer)37 studier
- Pankreaskreft31 studier
- Kolorektal kreft31 studier
- Metastatisk kreft28 studier
- Fedme26 studier
- Blærekreft24 studier
- Hjertesvikt24 studier
- Eggstokkreft22 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.